Provectus Pharma will be including salmon peptides from Biomega Group in a weight loss product called W8 Solution.
Photo © iStockphoto.com/hidesy
Provectus Pharma (Fjellhamar, Viken, Norway) will be including salmon peptides from Biomega Group (Hordaland, Norway) in a weight loss product called W8 Solution. The innovative combination of glucomannan, raspberry ketones, Vitamin C, and salmon peptides is designed to support satiety, as well as healthy blood sugar levels which will contribute to normal metabolism of fatty acids and energy.
“We are delighted to work with W8 Solution and include our salmon peptides in its unique patent pending slimming product. Processed from fresh Norwegian salmon by our natural enzymatic hydrolysis, Biomega peptides contain more than 90% hydrolysed proteins and over 20% collagen peptides (type I and III), which are proven to have a positive effect on skin health,” said Marianne Warnaer, director of global sales, at Biomega, in a press release. “In addition, our bioactive salmon peptides have anti-inflammatory properties, help maintain stable blood glucose levels and support weight management, making the ingredient beneficial for W8 Solution users.”
“W8 Solution is designed with simplicity in mind,” said Marcus Slinning, COO at Provectus Pharma AS, in a press release. “It’s been developed to help users lose weight without making major changes to their lifestyle. The active ingredients in W8 Solution suppress hunger, enabling users to eat smaller portions, while continuing to consume a healthy diet. The addition of chromium, magnesium and Vitamin C also aid in stabilizing blood sugar levels and improve blood vessel function, leading to a stronger immune system.”
W8 Solution is designed to be taken three times per day, approximately 30 minutes prior to each major meal. It is in powder form, available in sachets, and easily dissolves in a glass of water.